05-译后评论:提倡癌痛治疗规范化.pdf
http://www.100md.com
第1页 |
参见附件(36kb)。
临床综述
22 Br ue ra E, Be lzi le M, Pi tuskin E, F ainsinger R , Da rke A, Ha rsa nyi Z, et al .
Randomised double bl ind c ros sover tr ia l c omparing safety and effica cy of oral
cont rol le d re le ase oxycodone wi th cont rol led re le ase morphine in pa tients with
cance r pa in. J Clin Oncol 1998; 16: 3222-9.
23 Nicholson AB. Methadone for canc er pa in. Cochra ne Da ta ba se Syst Rev 2004;
( 2) : CD003971 .
24 Mui jsers RB , Wagstaff AJ . Tr ansde rmal fentanyl : an updated revie w of i ts
pha rmacological propert ies and therape ut ic effic acy in c hr onic canc er pain
cont rol . Drugs 2001; 61 : 2289 -307 .
25 Ahmedzai S, Brooks D. Transderma l fe ntanyl versus sus tained re le ase oral
morphine in canc er pa in : prefere nc e, efficac y and qual i ty of li fe. J P ain
Symptom Ma na ge 1997 ; 13: 254-61.
26 Donner B, Ze nz M, St rumpf M, R aber M. Long-term t re atment of canc er pain
with t ransderma l fenta nyl . J P a in Symptom Ma nage 1998; 15 : 168 -75 .
27 R adbruch L, Sabatowski R , Petzke F , Brunsc h-R adbruch A, Grond S,Lehma nn KA. Transderma l fe ntanyl for the mana geme nt of canc er pa in: a
survey of 1005 pat ients . P a ll iat Med 2001; 15 : 309 -21 .
28 Megens A, Artois K, Verme ire J , Me ert T, Awonters FH. Comparison of the
analges ic a nd intes t ina l effects of fentanyl and morphine in rats . J P ain
Symptom Ma na ge 1998 ; 15: 253-7.
29 R os s JR , Quigley C . Tra nsde rmal fentanyl : inform ed pr escribing is es sential .
Eur J P a in 2003; 7: 481-3.
30 Mer cadante S , Vi l la ri P , Fe rrer a P. Clinic al problem s wi th tr ansde rmal
fentanyl ti t rat ion from 25 to 50 microg/ hr . J P a in Symptom Ma na ge 2001; 21:
448-9.
31 P ortenoy RK, Payne R, Coluzzi P , Raschko JW, Lyss A, Busch MA, et al . Oral
transmucosal fentanyl ci trate ( OTFC) for the t reatme nt of breakthrough pain in
canc er pat ients : a controlled dose t it ration s tudy. Pa in 1999; 79: 303-12.
32 Sorge J , Si tt l R . Transderma l buprenorphine in the t rea tme nt of c hr onic pa in:
results of a phase II I, mult ic enter, random ised, double -bl ind, pla cebo-
cont rol le d s tudy. Cl in Ther 2004; 26: 1808 -20 .
33 Quigle y C. Opioid swi tc hing to improve pain r el ie f a nd dr ug tole rabi li ty. ......
22 Br ue ra E, Be lzi le M, Pi tuskin E, F ainsinger R , Da rke A, Ha rsa nyi Z, et al .
Randomised double bl ind c ros sover tr ia l c omparing safety and effica cy of oral
cont rol le d re le ase oxycodone wi th cont rol led re le ase morphine in pa tients with
cance r pa in. J Clin Oncol 1998; 16: 3222-9.
23 Nicholson AB. Methadone for canc er pa in. Cochra ne Da ta ba se Syst Rev 2004;
( 2) : CD003971 .
24 Mui jsers RB , Wagstaff AJ . Tr ansde rmal fentanyl : an updated revie w of i ts
pha rmacological propert ies and therape ut ic effic acy in c hr onic canc er pain
cont rol . Drugs 2001; 61 : 2289 -307 .
25 Ahmedzai S, Brooks D. Transderma l fe ntanyl versus sus tained re le ase oral
morphine in canc er pa in : prefere nc e, efficac y and qual i ty of li fe. J P ain
Symptom Ma na ge 1997 ; 13: 254-61.
26 Donner B, Ze nz M, St rumpf M, R aber M. Long-term t re atment of canc er pain
with t ransderma l fenta nyl . J P a in Symptom Ma nage 1998; 15 : 168 -75 .
27 R adbruch L, Sabatowski R , Petzke F , Brunsc h-R adbruch A, Grond S,Lehma nn KA. Transderma l fe ntanyl for the mana geme nt of canc er pa in: a
survey of 1005 pat ients . P a ll iat Med 2001; 15 : 309 -21 .
28 Megens A, Artois K, Verme ire J , Me ert T, Awonters FH. Comparison of the
analges ic a nd intes t ina l effects of fentanyl and morphine in rats . J P ain
Symptom Ma na ge 1998 ; 15: 253-7.
29 R os s JR , Quigley C . Tra nsde rmal fentanyl : inform ed pr escribing is es sential .
Eur J P a in 2003; 7: 481-3.
30 Mer cadante S , Vi l la ri P , Fe rrer a P. Clinic al problem s wi th tr ansde rmal
fentanyl ti t rat ion from 25 to 50 microg/ hr . J P a in Symptom Ma na ge 2001; 21:
448-9.
31 P ortenoy RK, Payne R, Coluzzi P , Raschko JW, Lyss A, Busch MA, et al . Oral
transmucosal fentanyl ci trate ( OTFC) for the t reatme nt of breakthrough pain in
canc er pat ients : a controlled dose t it ration s tudy. Pa in 1999; 79: 303-12.
32 Sorge J , Si tt l R . Transderma l buprenorphine in the t rea tme nt of c hr onic pa in:
results of a phase II I, mult ic enter, random ised, double -bl ind, pla cebo-
cont rol le d s tudy. Cl in Ther 2004; 26: 1808 -20 .
33 Quigle y C. Opioid swi tc hing to improve pain r el ie f a nd dr ug tole rabi li ty. ......
您现在查看是摘要介绍页,详见PDF附件(36KB,2页)。